InvestSMART

Pacific Smiles Group Limited (ASX: PSQ) - Announcements

DELISTED - Current share price for PSQ : $2.180

ASX company news and announcements for Pacific Smiles Group Limited (PSQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pacific Smiles Group Limited (PSQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pacific Smiles Group Limited (PSQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pacific Smiles Group Limited (PSQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Dividend/Distribution - PSQ 22 Feb 2023 9:44AM $1.320 $2.180 risen by 65.15%
- Appendix 4D and Interim Financial Report 22 Feb 2023 9:43AM $1.320 $2.180 risen by 65.15%
- 2023 Half Year Results Release Date and Conference Call 2 Feb 2023 9:50AM $1.450 $2.180 risen by 50.34%
- Final Director's Interest Notice - A Knott 20 Dec 2022 6:44PM $1.540 $2.180 risen by 41.56%
- Results of Extraordinary General Meeting 19 Dec 2022 1:50PM $1.595 $2.180 risen by 36.68%
- Withdrawal of Resolutions for upcoming EGM 13 Dec 2022 9:29AM $1.585 $2.180 risen by 37.54%
- Letter to Shareholders 12 Dec 2022 9:30AM $1.505 $2.180 risen by 44.85%
- 2022 AGM Results 28 Nov 2022 1:43PM $1.540 $2.180 risen by 41.56%
- 2022 Annual General Meeting Presentation 28 Nov 2022 8:42AM $1.510 $2.180 risen by 44.37%
- Becoming a substantial holder 28 Nov 2022 8:23AM $1.510 $2.180 risen by 44.37%
- Notice of Extraordinary General Meeting 17 Nov 2022 9:45AM $1.600 $2.180 risen by 36.25%
- Shareholder Update 17 Nov 2022 9:40AM $1.600 $2.180 risen by 36.25%
- Performance and Strategy Update 17 Nov 2022 9:36AM $1.600 $2.180 risen by 36.25%
- Postponement of Annual General Meeting to 28 November 2022 11 Nov 2022 9:47AM $1.540 $2.180 risen by 41.56%
- Notice Received Under Section 249D of the Corporations Act 7 Nov 2022 8:54AM $1.480 $2.180 risen by 47.30%
- Annual Report to shareholders 20 Oct 2022 5:03PM $1.290 $2.180 risen by 68.99%
- Notice of Annual General Meeting/Proxy Form 20 Oct 2022 5:01PM $1.290 $2.180 risen by 68.99%
- Appendix 4G and Corporate Governance Statement 17 Aug 2022 9:34AM $1.670 $2.180 risen by 30.54%
- FY2022 Results Presentation 17 Aug 2022 9:33AM $1.670 $2.180 risen by 30.54%
- 2022 Full Year Results 17 Aug 2022 9:31AM $1.670 $2.180 risen by 30.54%
- Appendix 4E and Financial Statements 17 Aug 2022 9:30AM $1.670 $2.180 risen by 30.54%
- TYM and Lloyds Register Collaborate for Guarantee of Origin 16 Aug 2022 9:45AM $1.615 $2.180 risen by 34.98%
- 2022 Full Year Results Release Date and Conference Call 2 Aug 2022 9:01AM $1.750 $2.180 risen by 24.57%
- Ceasing to be a substantial holder 14 Jul 2022 1:36PM $1.780 $2.180 risen by 22.47%
- June 2022 Patient Fee Performance and FY22 Earnings Guidance 14 Jul 2022 9:51AM $1.815 $2.180 risen by 20.11%

251 - 275 of 556 results

Page 11 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.